Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

Digestive and Liver Disease

Volumn 42, Issue 4, 2010, Pages 287-290

  Gisbert, J P ^a   Perez Aisa A ^b   Castro Fernandez M ^c   Barrio, J ^d   Rodrigo, L ^e   Cosme, A ^f   Gisbert, J L ^a   Marcos, S ^a   Moreno Otero, R ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL COSTA DEL SOL   (Spain)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f HOSPITAL DONOSTIA   (Spain)

Author keywords

Allergic; Eradication; Helicobacter pylori; Levofloxacin; Penicillin; Rescue

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; OMEPRAZOLE; PENICILLIN G;

ABDOMINAL PAIN; ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; ERADICATION THERAPY; HELICOBACTER INFECTION; HUMAN; MULTICENTER STUDY; MYALGIA; NAUSEA; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT FAILURE; UREA BREATH TEST; VOMITING;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OFLOXACIN; OMEPRAZOLE; PENICILLINS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77649186287     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.06.007     Document Type: Article

References (37)

1. Malfertheiner P., Megraud F., O'Morain C., et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56 (2007) 772-781
2. Chey W.D., and Wong B.C. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102 (2007) 1808-1825
3. Gisbert J.P., Calvet X., Gomollon F., et al. Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference. Med Clin (Barc) 125 (2005) 301-316
4. de Boer W.A., and Tytgat G.N. Regular review: treatment of Helicobacter pylori infection. BMJ 320 (2000) 31-34
5. Axon A.T. Treatment of Helicobacter pylori: an overview. Aliment Pharmacol Ther 14 Suppl. 3 (2000) 1-6
6. Gisbert J.P., and Pajares J.M. Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail. Aliment Pharmacol Ther 16 (2002) 1047-1057
7. Gisbert J.P., and Pajares J.M. Helicobacter pylori "rescue" therapy after failure of two eradication treatments. Helicobacter 10 (2005) 363-372
8. Gisbert J.P., Gisbert J.L., Marcos S., et al. Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin. Aliment Pharmacol Ther 22 (2005) 1041-1046
9. Rodriguez-Torres M., Salgado-Mercado R., Rios-Bedoya C.F., et al. High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin. Dig Dis Sci 50 (2005) 634-639
10. Gisbert J.P., Badia X., Roset M., et al. The TETRA study: a prospective evaluation of Helicobacter pylori 'test-and-treat' strategy on 736 patients in clinical practice. Helicobacter 9 (2004) 28-38
11. Gisbert J.P., Gonzalez L., Calvet X., et al. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 14 (2000) 1319-1328
12. Gisbert J.P., and Maria Pajares J. Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review. Med Clin (Barc) 116 (2001) 111-116
13. Peitz U., Hackelsberger A., and Malfertheiner P. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs 57 (1999) 905-920
14. Peitz U., Sulliga M., Wolle K., et al. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther 16 (2002) 315-324
15. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53 (2004) 1374-1384
16. Beales I.L. Efficacy of Helicobacter pylori eradication therapies: a single centre observational study. BMC Gastroenterol 1 (2001) 7
17. Gisbert J.P., Gonzalez L., and Calvet X. Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Helicobacter 10 (2005) 157-171
18. Houben M.H., Van Der Beek D., Hensen E.F., et al. A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 13 (1999) 1047-1055
19. Anderson V.R., and Perry C.M. Levofloxacin: a review of its use as a high-dose, short-course treatment for bacterial infection. Drugs 68 (2008) 535-565
20. Gisbert J.P., Bermejo F., Castro-Fernandez M., et al. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. Am J Gastroenterol 103 (2008) 71-76
21. Saad R.J., Schoenfeld P., Kim H.M., et al. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol 101 (2006) 488-496
22. Gisbert J.P., and Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 23 (2006) 35-44
23. Vaira D., Ricci C., Lanzini A., et al. How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy. Dig Dis 25 (2007) 203-205
24. Sanchez J.E., Saenz N.G., Rincon M.R., et al. Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones. J Antimicrob Chemother 46 (2000) 283-285
25. Tanaka M., Isogai E., Isogai H., et al. Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori. J Antimicrob Chemother 49 (2002) 1039-1040
26. Watanabe Y., Aoyama N., Shirasaka D., et al. Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy. Dig Liver Dis 35 (2003) 711-715
27. Antos D., Schneider-Brachert W., Bastlein E., et al. 7-Day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity. Helicobacter 11 (2006) 39-45
28. Yahav J., Shmuely H., Niv Y., et al. In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure. Diagn Microbiol Infect Dis 55 (2006) 81-83
29. Bilardi C., Dulbecco P., Zentilin P., et al. A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clin Gastroenterol Hepatol 2 (2004) 997-1002
30. Gatta L., Zullo A., Perna F., et al. A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses. Aliment Pharmacol Ther 22 (2005) 45-49
31. Matsumoto Y., Miki I., Aoyama N., et al. Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan. Dig Liver Dis 37 (2005) 821-825
32. Cammarota G., Cianci R., Cannizzaro O., et al. Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment Pharmacol Ther 14 (2000) 1339-1343
33. Di Caro S., Assunta Zocco M., Cremonini F., et al. Levofloxacin based regimens for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 14 (2002) 1309-1312
34. Gisbert J.P., Fernandez-Bermejo M., Molina-Infante J., et al. Levofloxacin, amoxicillin and omeprazole as first-line triple therapy for Helicobacter pylori eradication. J Clin Gastroenterol 43 4 (2009) 384-385
35. Marzio L., Coraggio D., Capodicasa S., et al. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole. Helicobacter 11 (2006) 237-242
36. Rispo A., Di Girolamo E., Cozzolino A., et al. Levofloxacin in first-line treatment of Helicobacter pylori infection. Helicobacter 12 (2007) 364-365
37. Croom K.F., and Goa K.L. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. Drugs 63 (2003) 2769-2802